Video

Aaron Lyss Outlines Lessons Learned From Data Analytics

In each performance period of the Oncology Care Model for which we've received data, we've seen different aspects of care that we can improve upon in the following 6 months, said Aaron Lyss, MBA, director of strategy and business development at Tennessee Oncology.

In each performance period of the Oncology Care Model for which we've received data, we've seen different aspects of care that we can improve upon in the following 6 months, said Aaron Lyss, MBA, director of strategy and business development at Tennessee Oncology.

Transcript:

Looking ahead, what are the unmet needs for the practice that could be assisted through a change in government policy?

I think the most critical aspect of government policy that can be addressed through alternative payment models is the payment schema supporting the transition from the fee-for-service environment to the value-based payment environment.

How do you use any lessons learned from data analytics to make any pivots or shifts in strategy?

I think in each performance period of the model for which we've received data, we've seen different aspects of care delivery that we can improve and focus on for the following 6 months. In several instances, this has had to do with the populations of patients in the specific types of cancers that we see in our data as opportunities to improve care delivery.

Newsletter

Stay ahead of policy, cost, and value—subscribe to AJMC for expert insights at the intersection of clinical care and health economics.

Related Videos
Merrill H. Stewart, MD
Nicolas Ferreyros, managing director, Community Oncology Alliance
Dr Ibrahim Aldoss
Jody Agena, PharmD, MBA, director of pharamcy operations, Virginia Cancer Specialists
Rachel Rohaidy, MD
Mansi Shah, MD
Miriam Freimer, MD
Screenshot of Ivo Abraham, PhD, RN, during a video interview
Dr Pankit Vachhani
Dr Ibrahim Aldoss
Related Content
AJMC Managed Markets Network Logo
CH LogoCenter for Biosimilars Logo